Show Summary Details
Page of

The lung in vasculitis 

The lung in vasculitis
The lung in vasculitis

G.A. Margaritopoulos

, and A.U. Wells

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 05 March 2021

Lung involvement in vasculitic disease can manifest as diffuse alveolar haemorrhage or as other pulmonary vasculopathy. Presenting features of diffuse alveolar haemorrhage include fever, weight loss, and other systemic symptoms in association with cough, breathlessness, and clinical signs suggestive of pneumonia. Haemoptysis may be present but is not invariable. A fall in haemoglobin over a day or longer suggests the diagnosis, and bronchoalveolar lavage is usually diagnostic. Other pulmonary vasculopathies present with breathlessness on exertion. Limited disease is generally treated with oral corticosteroid, given as monotherapy or in combination with a second-line immunosuppressive agent. Oral corticosteroid with either cyclophosphamide or rituximab are typically used to induce remission of generalized disease. Azathioprine or methotrexate with low-dose oral prednisolone are used to maintain remission.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.